NasdaqGS - Nasdaq Real Time Price USD

Seer, Inc. (SEER)

2.0450
-0.0250
(-1.21%)
As of 12:15:08 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
15,062
13,947
15,182
14,685
6,394
Cost of Revenue
7,554
7,115
8,155
8,400
3,205
Gross Profit
7,508
6,832
7,027
6,285
3,189
Operating Expense
103,148
106,933
110,490
103,520
74,662
Operating Income
-95,640
-100,101
-103,463
-97,235
-71,473
Net Non Operating Interest Income Expense
15,297
16,666
17,764
4,602
304
Other Income Expense
-5,326
-3,066
-578
-333
--
Pretax Income
-85,669
-86,501
-86,277
-92,966
-71,169
Tax Provision
199
98
0
--
--
Net Income Common Stockholders
-85,868
-86,599
-86,277
-92,966
-71,169
Diluted NI Available to Com Stockholders
-85,868
-86,599
-86,277
-92,966
-71,169
Basic EPS
-1.41
--
-1.35
-1.49
-1.17
Diluted EPS
-1.41
--
-1.35
-1.49
-1.17
Basic Average Shares
61,053.6760
--
63,850.4900
62,433.6130
60,863.9500
Diluted Average Shares
61,053.6760
--
63,850.4900
62,433.6130
60,863.9500
Total Operating Income as Reported
-95,640
-100,101
-103,463
-97,235
-71,473
Total Expenses
110,702
114,048
118,645
111,920
77,867
Net Income from Continuing & Discontinued Operation
-85,868
-86,599
-86,277
-92,966
-71,169
Normalized Income
-85,868
-86,599
-86,277
-92,966
-71,169
Interest Income
15,297
16,666
17,764
4,602
326
Interest Expense
--
--
--
0
22
Net Interest Income
15,297
16,666
17,764
4,602
304
EBIT
-95,640
-100,101
-103,463
-97,235
-71,147
EBITDA
-89,360
-93,925
-97,885
-93,293
-68,589
Reconciled Cost of Revenue
7,554
7,115
8,155
8,400
3,205
Reconciled Depreciation
6,280
6,176
5,578
3,942
2,558
Net Income from Continuing Operation Net Minority Interest
-85,868
-86,599
-86,277
-92,966
-71,169
Normalized EBITDA
-89,360
-93,925
-97,885
-93,293
-68,589
Tax Rate for Calcs
0.0002
0.0002
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 12/4/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ASMB Assembly Biosciences, Inc.
13.68
+1.92%
 
PRTC.L PureTech Health plc
128.00
-2.14%
 
CRGX CARGO Therapeutics, Inc.
4.1800
+1.46%
 
HLVX HilleVax, Inc.
1.9250
-2.28%
 
SPRO Spero Therapeutics, Inc.
0.6985
+7.30%
 
IPSC Century Therapeutics, Inc.
0.5534
-1.18%
 
VTYX Ventyx Biosciences, Inc.
1.4500
+3.57%
 
BOLT Bolt Biotherapeutics, Inc.
0.2951
+0.71%
 
TBPH Theravance Biopharma, Inc.
9.24
+0.43%
 
RPTX Repare Therapeutics Inc.
1.3400
0.00%